152 related articles for article (PubMed ID: 16826054)
21. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.
Ranoux D; Attal N; Morain F; Bouhassira D
Ann Neurol; 2008 Sep; 64(3):274-83. PubMed ID: 18546285
[TBL] [Abstract][Full Text] [Related]
22. Pain, quality of life, and spinal accessory nerve status after neck dissection.
Terrell JE; Welsh DE; Bradford CR; Chepeha DB; Esclamado RM; Hogikyan ND; Wolf GT
Laryngoscope; 2000 Apr; 110(4):620-6. PubMed ID: 10764008
[TBL] [Abstract][Full Text] [Related]
23. Botulinum toxin reduces anal spasm but has no effect on pain after haemorrhoidectomy.
Singh B; Box B; Lindsey I; George B; Mortensen N; Cunningham C
Colorectal Dis; 2009 Feb; 11(2):203-7. PubMed ID: 18462246
[TBL] [Abstract][Full Text] [Related]
24. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
25. Intraprostatic and bladder-neck injection of botulinum A toxin in treatment of males with bladder-neck dyssynergia: a pilot study.
Lim SK; Quek PL
Eur Urol; 2008 Mar; 53(3):620-5. PubMed ID: 17950522
[TBL] [Abstract][Full Text] [Related]
26. Shoulder and neck morbidity in quality of life after surgery for head and neck cancer.
van Wilgen CP; Dijkstra PU; van der Laan BF; Plukker JT; Roodenburg JL
Head Neck; 2004 Oct; 26(10):839-44. PubMed ID: 15390203
[TBL] [Abstract][Full Text] [Related]
27. Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial.
Singh JA; Mahowald ML; Noorbaloochi S
Transl Res; 2009 May; 153(5):205-16. PubMed ID: 19375681
[TBL] [Abstract][Full Text] [Related]
28. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.
Yuan RY; Sheu JJ; Yu JM; Chen WT; Tseng IJ; Chang HH; Hu CJ
Neurology; 2009 Apr; 72(17):1473-8. PubMed ID: 19246421
[TBL] [Abstract][Full Text] [Related]
29. Botulinum toxin vs. topical glyceryl trinitrate ointment for pain control in patients undergoing hemorrhoidectomy: a randomized trial.
Patti R; Almasio PL; Arcara M; Sammartano S; Romano P; Fede C; Di Vita G
Dis Colon Rectum; 2006 Nov; 49(11):1741-8. PubMed ID: 16990976
[TBL] [Abstract][Full Text] [Related]
30. Botulinum toxin in tension-type headache.
Relja M; Telarović S
J Neurol; 2004 Feb; 251 Suppl 1():I12-4. PubMed ID: 14991337
[TBL] [Abstract][Full Text] [Related]
31. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
Vadoud-Seyedi J; Simonart T
Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
[TBL] [Abstract][Full Text] [Related]
32. Morbidity of the neck after head and neck cancer therapy.
van Wilgen CP; Dijkstra PU; van der Laan BF; Plukker JT; Roodenburg JL
Head Neck; 2004 Sep; 26(9):785-91. PubMed ID: 15350024
[TBL] [Abstract][Full Text] [Related]
33. Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.
Slawek J; Friedman A; Potulska A; Krystkowiak P; Gervais C; Banach M; Ochudlo S; Budrewicz S; Reclawowicz D; Rynkowski M; Opala G
Funct Neurol; 2007; 22(2):95-100. PubMed ID: 17637212
[TBL] [Abstract][Full Text] [Related]
34. Preliminary results of a dose-finding study for botulinum toxin-A in patients with idiopathic overactive bladder: 100 versus 150 units.
Cohen BL; Barboglio P; Rodriguez D; Gousse AE
Neurourol Urodyn; 2009; 28(3):205-8. PubMed ID: 19058190
[TBL] [Abstract][Full Text] [Related]
35. Botulinum toxin A improves the quality of life of patients with neurogenic urinary incontinence.
Schurch B; Denys P; Kozma CM; Reese PR; Slaton T; Barron RL
Eur Urol; 2007 Sep; 52(3):850-8. PubMed ID: 17467889
[TBL] [Abstract][Full Text] [Related]
36. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
37. Pilot study of botulinum toxin type A in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles.
Jarvis SK; Abbott JA; Lenart MB; Steensma A; Vancaillie TG
Aust N Z J Obstet Gynaecol; 2004 Feb; 44(1):46-50. PubMed ID: 15089868
[TBL] [Abstract][Full Text] [Related]
38. The impact of neck dissection on health-related quality of life.
Laverick S; Lowe D; Brown JS; Vaughan ED; Rogers SN
Arch Otolaryngol Head Neck Surg; 2004 Feb; 130(2):149-54. PubMed ID: 14967742
[TBL] [Abstract][Full Text] [Related]
39. Neurogenic detrusor overactivity treated with english botulinum toxin a: 8-year experience of one single centre.
Del Popolo G; Filocamo MT; Li Marzi V; Macchiarella A; Cecconi F; Lombardi G; Nicita G
Eur Urol; 2008 May; 53(5):1013-19. PubMed ID: 17950989
[TBL] [Abstract][Full Text] [Related]
40. Treatment of whiplash associated neck pain with botulinum toxin-A: report of 8 cases.
Freund BJ; Schwartz M
J Rheumatol; 1999 Mar; 26(3):756-8. PubMed ID: 10090202
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
